tiprankstipranks
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market
JANX
Janux Therapeutics Inc
RESEARCH TOOLSreports

Janux Therapeutics Inc (JANX) Stock News & Sentiment

714 Followers
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
Premium
Ratings
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
1M ago
JANX
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
Premium
Ratings
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
1M ago
JANX
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
Premium
Ratings
Janux Therapeutics: Rebuilding Confidence After JANX007 Setback with 2026 Clinical Catalysts and Validated PSMA x CD3 Platform
1M ago
JANX
Janux Therapeutics Inks Global Oncology Collaboration With BMS
Premium
Company Announcements
Janux Therapeutics Inks Global Oncology Collaboration With BMS
2M ago
8K
JANX
Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile
Premium
Ratings
Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile
2M ago
JANX
3 ‘Strong Buy’ Stocks to Buy Today,12/29/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/29/2025, According to Top Analysts
3M ago
SOC
JANX
Maintaining Buy on Janux: Trial Progress and Undervalued Pipeline Create Compelling Risk–Reward
Premium
Ratings
Maintaining Buy on Janux: Trial Progress and Undervalued Pipeline Create Compelling Risk–Reward
3M ago
JANX
More JANX News >

JANX News on the Web

Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
Zacks
Bullish
Janux announces development candidate nomination under Bristol Myers collab
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Veeva Systems (VEEV) and Janux Therapeutics Inc (JANX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Janux Therapeutics Inc (JANX)
TipRanks News
Neutral
Janux Therapeutics price target lowered to $80 from $100 at Truist
TipRanks News
Neutral
Janux Therapeutics: Strong Cash Runway, Strategic Bristol-Myers Partnership, and 2026 Clinical Catalysts Underpin Buy Rating
TipRanks News
Bullish
Janux: Encouraging Early T Cell Engager Data, Broad Pipeline, and Strong Cash Runway Support Buy Rating
TipRanks News
Neutral
Janux Therapeutics price target lowered to $100 from $150 at Cantor Fitzgerald
TipRanks News
Neutral

News Score - Last 7 Days

Positive
JANX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JANX’s Media Buzz Sentiment?
2 articles about JANX were published this week. In an average week, 1 articles are published.
    What is JANX’s weekly average amount of articles?
    In an average week, 1 articles about JANX are published.
      What is JANX’s News Sentiment?
      100% of articles about JANX were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        PALIPalisade Bio
        LTRNLantern Pharma
        CNTBConnect Biopharma Holdings
        Showing the stocks with the most bullish news sentiment over the past week